Literature DB >> 3863109

Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

F Esch, A Baird, N Ling, N Ueno, F Hill, L Denoroy, R Klepper, D Gospodarowicz, P Böhlen, R Guillemin.   

Abstract

The two major mitogenic polypeptides for endothelial cells have been purified to homogeneity. The complete primary structure of bovine pituitary basic fibroblast growth factor (FGF) and the amino-terminal amino acid sequence of bovine brain acidic FGF have been established by gas-phase sequence analyses. Homogeneous preparations of these polypeptides are potent mitogens (basic FGF, ED50 approximately equal to 60 pg/ml; acidic FGF ED50 approximately equal to 6000 pg/ml) for many diverse cell types including capillary endothelial cells, vascular smooth muscle cells, and adrenocortical and granulosa cells; in vivo, basic FGF is a powerful angiogenic agent in the chick chorioallantoic membrane assay. The available protein sequence data demonstrate the existence of significant structural homology between the two polypeptides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863109      PMCID: PMC390746          DOI: 10.1073/pnas.82.19.6507

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  The angiogenic activity of the fibroblast and epidermal growth factor.

Authors:  D Gospodarowicz; H Bialecki; T K Thakral
Journal:  Exp Eye Res       Date:  1979-05       Impact factor: 3.467

2.  High-sensitivity amino acid analysis: methodology for the determination of amino acid compositions with less than 100 picomoles of peptides.

Authors:  P Böhlen; R Schroeder
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

3.  A computer program for predicting protein antigenic determinants.

Authors:  T P Hopp; K R Woods
Journal:  Mol Immunol       Date:  1983-04       Impact factor: 4.407

4.  Three different fibronectin mRNAs arise by alternative splicing within the coding region.

Authors:  J E Schwarzbauer; J W Tamkun; I R Lemischka; R O Hynes
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  Reduction of sulfoxides in peptides and proteins.

Authors:  R A Houghten; C H Li
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Purification and characterization of acidic fibroblast growth factor from bovine brain.

Authors:  K A Thomas; M Rios-Candelore; S Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  High and low molecular weight forms of endothelial cell growth factor.

Authors:  T Maciag; G A Hoover; R Weinstein
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

8.  Angiogenic activity from bovine retina: partial purification and characterization.

Authors:  P A D'Amore; B M Glaser; S K Brunson; A H Fenselau
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro.

Authors:  A Baird; P Böhlen; N Ling; R Guillemin
Journal:  Regul Pept       Date:  1985-04

10.  Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells.

Authors:  D Gospodarowicz; J Cheng; M Lirette
Journal:  J Cell Biol       Date:  1983-12       Impact factor: 10.539

View more
  142 in total

Review 1.  Molecular mechanisms regulating motor neuron development and degeneration.

Authors:  T J Kilpatrick; M Soilu-Hänninen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

3.  Partial purification and characterization of a growth factor from human hyperplastic prostatic tissues.

Authors:  A Dignass; A W Holldorf
Journal:  Urol Res       Date:  1992

Review 4.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 5.  Growth factors and the skeletal system.

Authors:  E Canalis; T L McCarthy; M Centrella
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

6.  Effects of basic fibroblast growth factor on bone formation in vitro.

Authors:  E Canalis; M Centrella; T McCarthy
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

7.  Acceleration of tensile strength of incisions treated with EGF and TGF-beta.

Authors:  G L Brown; L J Curtsinger; M White; R O Mitchell; J Pietsch; R Nordquist; A von Fraunhofer; G S Schultz
Journal:  Ann Surg       Date:  1988-12       Impact factor: 12.969

8.  Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.

Authors:  G D'Angelo; I Struman; J Martial; R I Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

9.  Basic fibroblast growth factor can mediate the early inductive events in renal development.

Authors:  A O Perantoni; L F Dove; I Karavanova
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.

Authors:  J D Zhang; L S Cousens; P J Barr; S R Sprang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.